Literature DB >> 17065834

Simulation of application strategies for local drug delivery to the inner ear.

Stefan K Plontke1, Alec N Salt.   

Abstract

Local, rather than systemic, drug delivery to the inner ear is becoming more widely used to treat inner ear disorders. While many substances are undergoing preclinical and clinical studies, it is equally important to develop appropriate drug delivery systems. Pharmacokinetic studies are technically demanding in animals and almost impossible in humans. Computer simulations have helped establish the basic principles of drug distribution in the inner ear. The distribution of methylprednisolone in the guinea pig cochlea has been simulated for different drug delivery systems based on kinetic parameters established in prior studies. Results were compared for different rates of drug clearance from the middle ear. Absolute and relative drug levels in the perilymph were highly dependent on how long the drug remained in the middle ear. For a brief (30 min) application, the basal to apical drug gradient was higher than for longer delivery times. These findings show that controlling middle ear drug clearance is of critical importance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065834      PMCID: PMC1751485          DOI: 10.1159/000095284

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  26 in total

1.  Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease.

Authors:  J Thomsen; S Charabi; M Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

Review 2.  Local inner-ear drug delivery and pharmacokinetics.

Authors:  Alec N Salt; Stefan K R Plontke
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

3.  Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.

Authors:  Stefan Plontke; Hubert Löwenheim; Serena Preyer; Patrick Leins; Klaus Dietz; Assen Koitschev; Rainer Zimmermann; Hans-Peter Zenner
Journal:  Acta Otolaryngol       Date:  2005-08       Impact factor: 1.494

4.  Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant.

Authors:  Richard D Kopke; Ronald A Wassel; Fadee Mondalek; Brian Grady; Kejian Chen; Jianzhong Liu; Don Gibson; Kenneth J Dormer
Journal:  Audiol Neurootol       Date:  2006-01-17       Impact factor: 1.854

5.  Inner ear drug delivery via a reciprocating perfusion system in the guinea pig.

Authors:  Zhiqiang Chen; Sharon G Kujawa; Michael J McKenna; Jason O Fiering; Mark J Mescher; Jeffrey T Borenstein; Erin E Leary Swan; William F Sewell
Journal:  J Control Release       Date:  2005-11-07       Impact factor: 9.776

6.  Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex.

Authors:  Robert Mynatt; Shane A Hale; Ruth M Gill; Stefan K Plontke; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-22

7.  Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.

Authors:  Hartmut Hahn; Bernd Kammerer; Andre DiMauro; Alec N Salt; Stefan K Plontke
Journal:  Hear Res       Date:  2006-01-25       Impact factor: 3.208

8.  Drug delivery to the cochlea using PLGA nanoparticles.

Authors:  Tetsuya Tamura; Tomoko Kita; Takayuki Nakagawa; Tsuyoshi Endo; Tae-Soo Kim; Tsutomu Ishihara; Yutaka Mizushima; Megumu Higaki; Juichi Ito
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

9.  Novel strategy for treatment of inner ears using a biodegradable gel.

Authors:  Tsuyoshi Endo; Takayuki Nakagawa; Tomoko Kita; Fukuichiro Iguchi; Tae-Soo Kim; Tetsuya Tamura; Koji Iwai; Yasuhiko Tabata; Juichi Ito
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

10.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

View more
  13 in total

Review 1.  Issues, indications, and controversies regarding intratympanic steroid perfusion.

Authors:  Mohamed Hamid; Dennis Trune
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 2.064

Review 2.  Innovative pharmaceutical approaches for the management of inner ear disorders.

Authors:  Umberto M Musazzi; Silvia Franzé; Francesco Cilurzo
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

3.  Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss.

Authors:  Stefan K Plontke; Alexander Glien; Torsten Rahne; Karsten Mäder; Alec N Salt
Journal:  Otol Neurotol       Date:  2014-08       Impact factor: 2.311

Review 4.  Intracochlear drug delivery systems.

Authors:  Jeffrey T Borenstein
Journal:  Expert Opin Drug Deliv       Date:  2011-05-26       Impact factor: 6.648

Review 5.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.

Authors:  Sophie Nyberg; N Joan Abbott; Xiaorui Shi; Peter S Steyger; Alain Dabdoub
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

6.  Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.

Authors:  Alec N Salt; Jared Hartsock; Stefan Plontke; Carl LeBel; Fabrice Piu
Journal:  Audiol Neurootol       Date:  2010-12-19       Impact factor: 1.854

7.  Dexamethasone concentration gradients along scala tympani after application to the round window membrane.

Authors:  Stefan K Plontke; Thorsten Biegner; Bernd Kammerer; Ursular Delabar; Alec N Salt
Journal:  Otol Neurotol       Date:  2008-04       Impact factor: 2.311

Review 8.  [Menière's disease : evidence and controversies].

Authors:  M Westhofen
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

9.  Hearing Changes After Intratympanic Steroids for Secondary (Salvage) Therapy of Sudden Hearing Loss: A Meta-Analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2018-08       Impact factor: 2.311

10.  Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane.

Authors:  Stefan K Plontke; Robert Mynatt; Ruth M Gill; Stefan Borgmann; Alec N Salt
Journal:  Laryngoscope       Date:  2007-07       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.